Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- Nature Careers
- The Ohio State University
- Duke University
- FAPESP - São Paulo Research Foundation
- Rutgers University
- University of London
- University of Luxembourg
- University of Maryland, Baltimore
- CNRS
- Chalmers University of Technology
- Delft University of Technology (TU Delft)
- Duke University Medical Center
- Institut Pasteur
- Institute of Physical Chemistry, Polish Academy of Sciences
- Johns Hopkins University
- KU LEUVEN
- Karolinska Institutet (KI)
- King's College London
- Leiden University
- Lunds universitet
- MOHAMMED VI POLYTECHNIC UNIVERSITY
- Medical Research Council
- Montana State University
- SUNY University at Buffalo
- Saint Louis University
- SciLifeLab
- Stanford University
- Technical University of Denmark
- The University of North Carolina at Chapel Hill
- Umeå universitet stipendiemodul
- University of Basel
- University of California, Los Angeles
- University of Colorado
- University of Florida
- University of Lund
- University of Miami
- University of Minnesota
- University of North Carolina at Chapel Hill
- University of Oslo
- University of Oxford
- University of Sydney
- University of Texas at Dallas
- University of Washington
- VIB
- Washington State University
- 35 more »
- « less
-
Field
-
novel proteins/antibodies and explore their biomedical applications. Our goal is to utilize these engineered proteins to precisely regulate intracellular signaling pathways, eventually translating
-
new techniques, most notably protein crystallography, cryo-electron microscopy, DNA sequencing and monoclonal antibodies. The LMB has a clear goal of understanding biological processes at the molecular
-
experience in CAR T and bispecific antibodies is a plus. If interested, please send a cover letter describing research interests, a CV, and the contact information of three professional references. Duke is an
-
critical biomolecules involved in this process, making anti-angiogenic treatments a promising cancer therapy strategy. Common treatments include monoclonal antibodies and tyrosine kinase inhibitors targeting
-
, vaccinology, antibody function, systems serology, immune correlates of protection and evaluation of immunity to infection and vaccination in animal models Qualifications Minimum qualifications include a Ph.D